Zhang HT - Search Results

1

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells.

He CX, Ai J, Xing WQ, Chen Y, Zhang HT, Huang M, Hu YH, Ding J, Geng MY. He CX, et al. Among authors: zhang ht. Acta Pharmacol Sin. 2014 Jan;35(1):89-97. doi: 10.1038/aps.2013.125. Epub 2013 Nov 18. Acta Pharmacol Sin. 2014. PMID: 24241352 Free PMC article.

2

SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo.

Wang L, Ai J, Shen Y, Zhang H, Peng X, Huang M, Zhang A, Ding J, Geng M. Wang L, et al. Cancer Lett. 2014 Aug 28;351(1):143-50. doi: 10.1016/j.canlet.2014.05.012. Epub 2014 May 28. Cancer Lett. 2014. PMID: 24880078

3

SOMG-833, a novel selective c-MET inhibitor, blocks c-MET-dependent neoplastic effects and exerts antitumor activity.

Zhang HT, Wang L, Ai J, Chen Y, He CX, Ji YC, Huang M, Yang JY, Zhang A, Ding J, Geng MY. Zhang HT, et al. Among authors: zhang a. J Pharmacol Exp Ther. 2014 Jul;350(1):36-45. doi: 10.1124/jpet.114.214817. Epub 2014 Apr 16. J Pharmacol Exp Ther. 2014. PMID: 24741075

4

Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.

Yue X, Ai J, Xu Y, Chen Y, Huang M, Yang X, Hu B, Zhang H, He C, Yang X, Tang W, Peng X, Dong L, Wang H, Fan J, Ding J, Geng M. Yue X, et al. Hepatology. 2017 Jun;65(6):1948-1962. doi: 10.1002/hep.29036. Epub 2017 Apr 28. Hepatology. 2017. PMID: 28073159

5

Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143-50].

Wang L, Ai J, Shen Y, Zhang H, Peng X, Huang M, Zhang A, Ding J, Geng M. Wang L, et al. Cancer Lett. 2020 Aug 28;486:71-72. doi: 10.1016/j.canlet.2020.05.010. Epub 2020 May 29. Cancer Lett. 2020. PMID: 32475789 No abstract available.

6

Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity.

Qin M, Tian Y, Han X, Cao Q, Zheng S, Liu C, Wu X, Liu L, Meng Y, Wang X, Zhang H, Hou Y. Qin M, et al. Bioorg Med Chem. 2020 Jun 1;28(11):115486. doi: 10.1016/j.bmc.2020.115486. Epub 2020 Apr 3. Bioorg Med Chem. 2020. PMID: 32305182

7

Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.

Wu X, Xue X, Wang L, Wang W, Han J, Sun X, Zhang H, Liu Y, Che X, Yang J, Wu C. Wu X, et al. Eur J Pharmacol. 2018 May 15;827:1-12. doi: 10.1016/j.ejphar.2018.02.039. Epub 2018 Mar 13. Eur J Pharmacol. 2018. PMID: 29547841

8

Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents.

Qin M, Yan S, Wang L, Zhang H, Zhao Y, Wu S, Wu D, Gong P. Qin M, et al. Eur J Med Chem. 2016 Jun 10;115:1-13. doi: 10.1016/j.ejmech.2016.02.071. Epub 2016 Mar 3. Eur J Med Chem. 2016. PMID: 26991938

9

Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.

Qin M, Meng Y, Yang H, Liu L, Zhang H, Wang S, Liu C, Wu X, Wu D, Tian Y, Hou Y, Zhao Y, Liu Y, Xu C, Wang L. Qin M, et al. J Med Chem. 2021 May 13;64(9):5519-5534. doi: 10.1021/acs.jmedchem.0c01958. Epub 2021 May 3. J Med Chem. 2021. PMID: 33938739

10

Novel 6-methoxycarbonyl indolinones bearing a pyrrole Mannich base moiety as angiokinase inhibitors.

Qin M, Yan S, Wang L, Zhang H, Tian Y, Zhao Y, Gong P. Qin M, et al. Bioorg Med Chem. 2017 Mar 15;25(6):1778-1786. doi: 10.1016/j.bmc.2017.01.039. Epub 2017 Jan 25. Bioorg Med Chem. 2017. PMID: 28190652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

899 results

Search Page

Filters